Incidence Trends and Survival Prediction of Malignant Skin Cancer: A SEER-Based Study
- PMID: 35313550
- PMCID: PMC8934145
- DOI: 10.2147/IJGM.S340620
Incidence Trends and Survival Prediction of Malignant Skin Cancer: A SEER-Based Study
Abstract
Purpose: This study aimed to analyze the incidence trend and further explore the risk factors influencing the survival among patients of malignant skin cancer in America.
Methods: Age-adjusted incidence rates, annual percentage change (APC) of different sex and ethnicity in 1973-2015 and patient records were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate analysis and multivariate Cox regression were used to analyze risk factors influencing the survival in skin cancer patients. Survival curves and nomograms were constructed to evaluate the survival prediction by R.
Results: The overall age-adjusted incidence of skin cancer increased in America from 1973 to 2005 (APC = 2.8%, 95% CI: 2.6-2.9%, P < 0.05), particularly in white patients, 66-year-old people, and males. The 3- and 5-year overall survival (OS) rates were 51.4% and 33.8%, respectively. Independent predictors for short OS include age over 65, white ethnicity, other marital status and no surgery (P < 0.05). Stage was not an independent factor of survival (P > 0.05). The nomogram with a C-index of 0.72 (95% CI: 0.71-0.73) matched an appropriate calibration curve.
Conclusion: Incidence of skin cancer in America was on the rise during 1973-2015 based on SEER database. Age, ethnicity, marital status and surgical history were related with survival of malignant skin cancer. Nomograms were effective tools for predicting the survival prognosis.
Keywords: SEER; incidence; malignant skin cancer; nomogram; overall survival; primary site surgery.
© 2022 Zhu et al.
Conflict of interest statement
All authors declare no conflicts of interest in this work.
Figures






Similar articles
-
Incidence trends and survival prediction of hepatoblastoma in children: a population-based study.Cancer Commun (Lond). 2019 Oct 24;39(1):62. doi: 10.1186/s40880-019-0411-7. Cancer Commun (Lond). 2019. PMID: 31651371 Free PMC article.
-
Trends of incidence and prognosis of upper tract urothelial carcinoma.Bosn J Basic Med Sci. 2021 Oct 1;21(5):607-619. doi: 10.17305/bjbms.2020.5345. Bosn J Basic Med Sci. 2021. PMID: 33357210 Free PMC article.
-
Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma.Front Endocrinol (Lausanne). 2021 Jun 21;12:684668. doi: 10.3389/fendo.2021.684668. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34234744 Free PMC article.
-
Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study.Int J Clin Oncol. 2021 Feb;26(2):387-398. doi: 10.1007/s10147-020-01813-8. Epub 2020 Oct 28. Int J Clin Oncol. 2021. PMID: 33113018
-
Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.BMC Urol. 2021 Nov 25;21(1):162. doi: 10.1186/s12894-021-00929-x. BMC Urol. 2021. PMID: 34823525 Free PMC article.
Cited by
-
Integration of immunotherapy and radiotherapy in a therapeutic algorithm for locally advanced squamous cell skin cancer.Med Oncol. 2025 Jun 4;42(7):238. doi: 10.1007/s12032-025-02785-3. Med Oncol. 2025. PMID: 40465096 Free PMC article.
-
Biomedical application of terahertz imaging technology: a narrative review.Quant Imaging Med Surg. 2023 Dec 1;13(12):8768-8786. doi: 10.21037/qims-23-526. Epub 2023 Sep 27. Quant Imaging Med Surg. 2023. PMID: 38106329 Free PMC article. Review.
-
Current status of artificial intelligence methods for skin cancer survival analysis: a scoping review.Front Med (Lausanne). 2024 Apr 22;11:1243659. doi: 10.3389/fmed.2024.1243659. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38711781 Free PMC article.
References
-
- Lin Z, Du J, Lu C, Wang J. Risk factors of new symptomatic vertebral compression fractures after percutaneous vertebroplasty. Int J Clin Exp Med. 2019;12(1):949–954.
-
- Liu-Smith F, Jia J, Zheng Y. UV-induced molecular signaling differences in melanoma and non-melanoma skin cancer. Adv Exp Med Biol. 2017;996:27–40. - PubMed
LinkOut - more resources
Full Text Sources